Top Buy
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Codexis Inc. | 5 | 2 | 1 | 0 | €3.38 | €8.36 | 147.342% |
| Syros Pharmaceuticals Inc. | 5 | 1 | 0 | 1 | €5.05 | €12.80 | 153.495% |
| Purple Biotech Ltd. ADR | 5 | 0 | 1 | 0 | €0.46 | €9.21 | 1901.522% |
| Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.12 | €19.86 | 224.855% |
| GSK plc ADR | 4 | 0 | 0 | 0 | €42.00 | - | - |
| Healthstream Inc. | 4 | 0 | 0 | 0 | €25.00 | €29.29 | 17.171% |
| Vanda Pharmaceuticals | 4 | 0 | 0 | 0 | €4.94 | €5.00 | 1.215% |
| Quest Diagnostics Inc. | 4 | 0 | 1 | 0 | €128.50 | €144.44 | 12.408% |
| Chimerix Inc. | 4 | 1 | 0 | 0 | €0.90 | €5.51 | 512.733% |
| Lightpath Techs A | 4 | 0 | 1 | 0 | €1.30 | €2.78 | 114.200% |
| Community Health Systems Inc. | 4 | 3 | 1 | 0 | €3.34 | €5.36 | 60.611% |
| Cerus Corp. | 4 | 0 | 1 | 0 | €1.89 | €3.26 | 72.291% |
| Sartorius AG VZO | 4 | 0 | 0 | 0 | €291.70 | - | - |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
| Canopy Growth Corp | 4 | 0 | 0 | 0 | €0.47 | €1.75 | 273.134% |
| Phibro Animal Health Corp. A | 4 | 2 | 0 | 1 | €16.60 | €12.06 | -27.325% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €97.00 | €124.85 | 28.709% |
| Compugen Ltd. | 3 | 2 | 1 | 0 | €1.98 | €3.67 | 85.308% |
| Merck KGaA | 3 | 1 | 0 | 0 | €165.95 | €146.00 | -12.022% |
| Abeona Therapeutics Inc. | 3 | 1 | 1 | 0 | €4.50 | €34.41 | 664.724% |
| Paul Hartmann AG | 3 | 0 | 0 | 0 | €204.00 | - | - |
| Apellis Pharmaceuticals | 3 | 0 | 0 | 0 | €38.96 | €70.00 | 79.695% |
| Heidelberg Pharma AG | 3 | 0 | 0 | 0 | €2.92 | - | - |
| Vitrolife AB | 3 | 0 | 0 | 0 | €15.73 | - | - |
| Perrigo Co. plc | 3 | 0 | 0 | 0 | €28.08 | €35.99 | 28.153% |